Biosimilar
- Human Insulin rDNA
- Recombinant Granulocyte colony stimulating factor- Filgrastim
- Recombinant Interferon beta-1a
- Follicle stimulating hormone
- Recombinant chorionic gonadotrophin hormone r-hCG
- State of the art cGMP Facility
- 7,000 sq. meters. facility with HVAC system
- Vial to vial single-use technology and closed processing
- Recombinant Erythropoietin
- Recombinant Interferon α
- Recombinant pegylated Interferon
- Recombinant Pegylated GCSF
Moncolonal Antibodies Biosimilars:
- RITUXIMAB
- TRASTUZUMAB
- CEUTIXIMAB
- BEVACIZUMAB
- INFLIXIMAB
- ADALIMUMAB
- RANITIZUMAB
